Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene

被引:21
作者
Liu, WD [1 ]
Shimomura, S [1 ]
Imanishi, H [1 ]
Iwamoto, Y [1 ]
Ikeda, N [1 ]
Saito, M [1 ]
Ohno, M [1 ]
Hara, N [1 ]
Yamamoto, T [1 ]
Nakamura, H [1 ]
Hada, T [1 ]
机构
[1] Hyogo Med Univ, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, Nishinomiya, Hyogo 6638501, Japan
关键词
hemochromatosis; ferroportin; 1; iron responsive element; siderosis; point mutation;
D O I
10.2169/internalmedicine.44.285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The HFE, H ferritin, TFR2, and ferroportin 1 genes of a Japanese patient diagnosed as having hemochromatosis were amplified by PCR and sequenced. A novel mutation in the ferroportin 1 was found in the patient. It was located in the noncoding region of the ferroportin 1; nucleotide 117 adenine was changed to guanine, 7 nucleotides downstream the iron responsive element (IRE) region. This mutation was not found in the patient's son or daughter, or in 50 healthy individuals. It was suggested that the mutation in the ferroportin I may be related to hemochromatosis of this patient.
引用
收藏
页码:285 / 289
页数:5
相关论文
共 15 条
[1]   The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 [J].
Camaschella, C ;
Roetto, A ;
Cali, A ;
De Gobbi, M ;
Garozzo, G ;
Carella, M ;
Majorano, N ;
Totaro, A ;
Gasparini, P .
NATURE GENETICS, 2000, 25 (01) :14-15
[2]   Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) [J].
Cazzola, M ;
Cremonesi, L ;
Papaioannou, M ;
Soriani, N ;
Kioumi, A ;
Charalambidou, A ;
Paroni, R ;
Romtsou, K ;
Levi, S ;
Ferrari, M ;
Arosio, P ;
Christakis, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) :539-546
[3]   Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3) [J].
Devalia, V ;
Carter, K ;
Walker, AP ;
Perkins, SJ ;
Worwood, M ;
May, A ;
Dooley, JS .
BLOOD, 2002, 100 (02) :695-697
[4]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[5]   Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations [J].
Hetet, G ;
Devaux, I ;
Soufir, N ;
Grandchamp, B ;
Beaumont, C .
BLOOD, 2003, 102 (05) :1904-1910
[6]   Idiopathic hemochromatosis with the mutation of Ala176Val heterozygous for HFE gene [J].
Imanishi, H ;
Liu, WD ;
Cheng, JD ;
Ikeda, N ;
Amuro, Y ;
Hada, T .
INTERNAL MEDICINE, 2001, 40 (06) :479-483
[7]   Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload [J].
Jouanolle, AM ;
Douabin-Gicquel, V ;
Halimi, C ;
Loréal, O ;
Fergelot, P ;
Delacour, T ;
de Lajarte-Thirouard, AS ;
Turlin, B ;
Le Gall, JY ;
Cadet, E ;
Rochette, J ;
David, V ;
Brissot, P .
JOURNAL OF HEPATOLOGY, 2003, 39 (02) :286-289
[8]   A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload [J].
Kato, J ;
Fujikawa, K ;
Kanda, M ;
Fukuda, N ;
Sasaki, K ;
Takayama, T ;
Kobune, M ;
Takada, K ;
Takimoto, R ;
Hamada, H ;
Ikeda, T ;
Niitsu, Y .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (01) :191-197
[9]   Familial hypocholinesterasemia found in a family and a new confirmed mutation [J].
Lu, WD ;
Hada, T ;
Fukui, K ;
Imanishi, H ;
Matsuoka, N ;
Iwasaki, A ;
Higashino, K .
INTERNAL MEDICINE, 1997, 36 (01) :9-13
[10]   Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene [J].
Montosi, G ;
Donovan, A ;
Totaro, A ;
Garuti, C ;
Pignatti, E ;
Cassanelli, S ;
Trenor, CC ;
Gasparini, P ;
Andrews, NC ;
Pietrangelo, A .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (04) :619-623